Cost-Effectiveness Analysis of Initiating Type 2 Diabetes Therapy with a Sodium–Glucose Cotransporter 2 Inhibitor Versus Conventional Therapy in Japan
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cost-Effectiveness Analysis of Initiating Type 2 Diabetes Therapy with a Sodium–Glucose Cotransporter 2 Inhibitor Versus Conventional Therapy in Japan
Authors
Keywords
-
Journal
Diabetes Therapy
Volume 13, Issue 7, Pages 1367-1381
Publisher
Springer Science and Business Media LLC
Online
2022-06-17
DOI
10.1007/s13300-022-01270-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Manifestation of Heart Failure and Chronic Kidney Disease are Associated with Increased Mortality Risk in Early Stages of Type 2 Diabetes Mellitus: Analysis of a Japanese Real-World Hospital Claims Database
- (2022) Takashi Kadowaki et al. Diabetes Therapy
- Healthcare resource utilization after initiation of sodium‐glucose co‐transporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors or other glucose‐lowering drugs in Japanese patients with type 2 diabetes
- (2021) Shun Kohsaka et al. DIABETES OBESITY & METABOLISM
- Lower heart failure and chronic kidney disease risks associated with sodium‐glucose cotransporter‐2 inhibitor use in Japanese type 2 diabetes patients without established cardiovascular and renal diseases
- (2021) Issei Komuro et al. DIABETES OBESITY & METABOLISM
- 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
- (2021) Frank L J Visseren et al. EUROPEAN HEART JOURNAL
- Design and rationale of DISCOVER global registry in type 2 diabetes: Real-world insights of treatment patterns and its relationship with cardiovascular, renal, and metabolic multimorbidities
- (2021) Kamlesh Khunti et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Quality of Care in Chronic Kidney Disease and Incidence of End-Stage Renal Disease in Older Patients
- (2020) Shingo Fukuma et al. MEDICAL CARE
- Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: a large multinational cohort study
- (2020) Kåre I. Birkeland et al. DIABETES OBESITY & METABOLISM
- Sodium–glucose cotransporter 2 inhibitors compared with other glucose‐lowering drugs in Japan: Subanalyses of the CVD‐REAL 2 Study
- (2020) Shun Kohsaka et al. Journal of Diabetes Investigation
- Baseline Characteristics of Patients with Type 2 Diabetes Initiating Second-Line Treatment in Japan: Findings from the J-DISCOVER Study
- (2020) Naoto Katakami et al. Diabetes Therapy
- Cost-Effectiveness of a Continuous Glucose Monitoring Mobile App for Patients With Type 2 Diabetes Mellitus: Analysis Simulation
- (2020) Shintaro Tsuji et al. JOURNAL OF MEDICAL INTERNET RESEARCH
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dapagliflozin in Patients with Chronic Kidney Disease
- (2020) Hiddo J.L. Heerspink et al. NEW ENGLAND JOURNAL OF MEDICINE
- 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2021
- (2020) DIABETES CARE
- 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2021
- (2020) DIABETES CARE
- Incidence of adverse cardiovascular events in type 2 diabetes mellitus patients after initiation of the glucose‐lowering agents: A population‐based community study from the Shizuoka Kokuho Database
- (2020) Shun Kohsaka et al. Journal of Diabetes Investigation
- Treatment patterns, persistence and adherence rates in patients with type 2 diabetes mellitus in Japan: a claims-based cohort study
- (2019) Rimei Nishimura et al. BMJ Open
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- WITHDRAWN: Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition
- (2019) Pouya Saeedi et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
- (2019) Francesco Cosentino et al. EUROPEAN HEART JOURNAL
- Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study
- (2019) Hiddo J L Heerspink et al. Lancet Diabetes & Endocrinology
- Burden of cardio-renal-metabolic conditions in adults with type 2 diabetes within the Diabetes Collaborative Registry
- (2018) Suzanne V. Arnold et al. DIABETES OBESITY & METABOLISM
- Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2018) Aidin Rawshani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of health utility values for diabetic complications, treatment regimens, glycemic control and other subjective symptoms in diabetic patients using the EQ-5D-5L
- (2018) Mitsuyoshi Takahara et al. ACTA DIABETOLOGICA
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- The impact of carperitide usage on the cost of hospitalization and outcome in patients with acute heart failure: High value care vs. low value care campaign in Japan
- (2017) Atsushi Mizuno et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Diabetes with early kidney involvement may shorten life expectancy by 16 years
- (2017) Chi Pang Wen et al. KIDNEY INTERNATIONAL
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Differences between determinants of in-hospital mortality and hospitalisation costs for patients with acute heart failure: a nationwide observational study from Japan
- (2017) Noriko Sasaki et al. BMJ Open
- Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial
- (2017) Kohjiro Ueki et al. Lancet Diabetes & Endocrinology
- Evaluating the Quality of Comprehensive Cardiometabolic Care for Patients With Type 2 Diabetes in the U.S.: The Diabetes Collaborative Registry: Table 1
- (2016) Suzanne V. Arnold et al. DIABETES CARE
- Comparison of health-related quality of life between type 2 diabetic patients with and without locomotive syndrome
- (2016) Rie Asakura et al. Environmental Health and Preventive Medicine
- Cost-effectiveness Analysis of Apixaban against Warfarin for Stroke Prevention in Patients with Nonvalvular Atrial Fibrillation in Japan
- (2015) Isao Kamae et al. CLINICAL THERAPEUTICS
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Validation of the IMS CORE Diabetes Model
- (2014) Phil McEwan et al. VALUE IN HEALTH
- Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States
- (2013) Ronald C.W. Ma et al. Annals of the New York Academy of Sciences
- Medical Care for Chronic-Phase Stroke in Japan
- (2012) Naoyuki HATTORI et al. NEUROLOGIA MEDICO-CHIRURGICA
- Cost-effectiveness of chronic kidney disease mass screening test in Japan
- (2011) Masahide Kondo et al. Clinical and Experimental Nephrology
- Event Rates, Hospital Utilization, and Costs Associated with Major Complications of Diabetes: A Multicountry Comparative Analysis
- (2010) Philip M. Clarke et al. PLOS MEDICINE
- Effect of chronic kidney disease on individual and population medical expenditures in the Japanese population
- (2009) Aya Higashiyama et al. HYPERTENSION RESEARCH
- Chronic Kidney Disease as a Predictor of Cardiovascular Disease (from the Framingham Heart Study)
- (2008) Nisha I. Parikh et al. AMERICAN JOURNAL OF CARDIOLOGY
- Cost-Utility Analysis of Antihypertensive Combination Therapy in Japan by a Monte Carlo Simulation Model
- (2008) Ikuo SAITO et al. HYPERTENSION RESEARCH
- Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes
- (2008) Peter Gæde et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More